Medtronic’s Affera Sphere-360 is a single-shot device, putting it in direct competition with Boston Scientific’s Farawave ...

Medtronic announced two new milestones for its Affera Sphere-360 catheter for pulsed field ablation (PFA) procedures.

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

Anteris Technologies says Medtronic will make a strategic investment of up to $90 million in the transcatheter heart valve ...

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Robert Kowal, MD, tells MD+DI how he became involved with the development of Medtronic's Micra leadless pacemaker.

David Dinsmoor, the local Medtronic engineer who worked on Inceptiv Medtronic researchers say a recently approved closed-loop spinal cord stimulator marks one of the company’s biggest breakthroughs in ...

Jan 12 (Reuters) - Medtronic has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a major industry ...

"It is unknown at this time if there will be additional litigation surrounding this specific product," Rosalie Louis of Lynch ...

Medtronic is a healthcare behemoth, developing and manufacturing medical devices for chronic diseases, with a broad and dominant portfolio of industry-leading products. The company has increased its ...

Medtronic is an undervalued AI stock with an elite dividend program. Artificial intelligence (AI) is ushering in a new era of innovation that promises to upend industries across the spectrum, and the ...